1. Altered CD45 expression in C77G carriers influences immune function and outcome of hepatitis C infection. Issue 8 (27th February 2006) Authors: Dawes, R; Hennig, B; Irving, W; Petrova, S; Boxall, S; Ward, V; Wallace, D; Macallan, D C; Thursz, M; Hill, A; Bodmer, W; Beverley, P C L; Tchilian, E Z Journal: Journal of medical genetics Issue: Volume 43:Issue 8(2006) Page Start: 678 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Best practice in primary care pathology: review 7. Issue 5 (17th October 2006) Authors: Smellie, W S A; Forth, J; Smart, S R S; Galloway, M J; Irving, W; Bareford, D; Collinson, P O; Kerr, K G; Summerfield, G; Carey, P J; Minhas, Rubin Journal: Journal of clinical pathology Issue: Volume 60:Issue 5(2007) Page Start: 458 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Clinical relapses and disease activity on magnetic resonance imaging associated with viral upper respiratory tract infections in multiple sclerosis. Issue 6 (1st June 1998) Authors: Edwards, S; Zvartau, M; Clarke, H; Irving, W; Blumhardt, L D Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 64:Issue 6(1998) Page Start: 736 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Detection of cytomegalovirus using PCR in serum from renal transplant recipients. Issue 6 (June 1995) Authors: Cunningham, R; Harris, A; Frankton, A; Irving, W Journal: Journal of clinical pathology Issue: Volume 48:Issue 6(1995) Page Start: 575 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Hepatitis G virus infection in lymphoma and in blood donors. Issue 9 (September 1998) Authors: Minton, J; Iqbal, A; Eskiturk, A; Irving, W; Davies, J Journal: Journal of clinical pathology Issue: Volume 51:Issue 9(1998) Page Start: 676 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P10: Increasing uptake of hepatitis C treatment in England between 2002 and 2010. (23rd October 2013) Authors: Lattimore, S; Irving, W; Collins, S; Penman, C; Ramsay, M Journal: Journal of viral hepatitis Issue: Volume 20(2013)supplement 3 Page Start: 20 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P19: Ribavirin‐boronic acid loaded nanoparticles: a possible route to improve hepatitis C treatment. (23rd October 2013) Authors: Abo‐zeid, Y; Irving, W; Thomson, B; Mantovani, G; Garnett, M Journal: Journal of viral hepatitis Issue: Volume 20(2013)supplement 3 Page Start: 26 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P22: Nanoparticle delivery systems for HCV treatment: do nanoparticles avoid uptake by erythrocytes?. (23rd October 2013) Authors: Abo‐zeid, Y; Irving, W; Thomson, B; Garnett, M Journal: Journal of viral hepatitis Issue: Volume 20(2013)supplement 3 Page Start: 28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P46 The prediction of liver related outcomes using histological tools as an endpoint for studies evaluating anti-fibrotic therapies. (6th September 2011) Authors: Dolman, G E; Li, G; Burgess, G; Gray, T; Zaitoun, A M; Irving, W; Guha, I N Journal: Gut Issue: Volume 60:(2011)Supplement 2 Page Start: A22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P63 Ribavirin uptake by primary human hepatocytes corresponds to equilibrative nucleoside transporter 1 expression. (6th September 2011) Authors: Baloch, B K; Chen, L; Ilyas, M; Irving, W; Thomson, B J Journal: Gut Issue: Volume 60:(2011)Supplement 2 Page Start: A29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗